; or (C) other data as determined appropriate by the Director. (3) Privilege and confidentiality The provisions of section 922 shall apply to patient safety data submitted under this subsection. 946. The National Healthcare Acquired Infection and Medical Error Reporting Accountability Study (a) In General The Director of the Office shall conduct, directly or through a contract with patient safety organizations or qualified individuals or institutions, an analysis of the patient safety data in the Database and other available data to determine performance and systems standards, tools, and best practices (including peer review) for doctors and other health care providers necessary to prevent medical errors, improve patient safety, and increase accountability within the health care system. Such analysis shall also consider the value of increasing the transparency of the patient safety data to include the identity of health care providers and provide recommendations for improvements to the peer review process. (b) Report and Recommendations Not later than 2 years after the date of enactment of this section, the Director of the Office shall submit to Congress and make available to States, State medical boards, and the public a report that describes the results of the study carried out under subsection (a) and contains recommendations for Congress based on the findings of the report. .